Mitchell C. Posner to Head and Neck Neoplasms
This is a "connection" page, showing publications Mitchell C. Posner has written about Head and Neck Neoplasms.
Connection Strength
1.070
-
The Italian Collaborative Group sets a standard for the treatment of locally advanced head and neck cancer. Ann Oncol. 2017 09 01; 28(9):2051-2054.
Score: 0.364
-
Controversies and role of HPV16 in recurrent/metastatic squamous cell cancers of the head and neck. Ann Oncol. 2014 Aug; 25(8):1667-8.
Score: 0.290
-
Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 2001 Nov 01; 51(3):599-604.
Score: 0.121
-
Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden. Ann Oncol. 2019 05 01; 30(5):744-756.
Score: 0.102
-
Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions. Ann Oncol. 2018 05 01; 29(5):1130-1140.
Score: 0.095
-
Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancers. Oral Oncol. 2007 Mar; 43(3):289-300.
Score: 0.042
-
Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer. J Clin Oncol. 2001 Jan 15; 19(2):289-98.
Score: 0.029
-
Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 1994 Dec 01; 30(5):1043-50.
Score: 0.019
-
Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM). Cancer Treat Rep. 1981 Sep-Oct; 65(9-10):787-91.
Score: 0.008